Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Pancragen
A short synthetic peptide bioregulator (Lys-Glu-Asp-Trp) from the Khavinson family, marketed for pancreatic/metabolic support. Evidence is largely Russian-language and preclinical.
Proposed tissue-specific peptide-bioregulator activity in pancreatic tissue; not established by independent research.
Primarily Russian institutional studies; no large independent controlled human trials.
Typical Dose
Per research protocol
Frequency
Varies
Route
SubQ
Notes
Khavinson short-peptide bioregulator.
Aggregated from 6 lab-verified Certificates of Analysis uploaded directly by labs. Purity averages exclude values outside [50%, 100%] to filter unit-misreads.
COAs
6
Verified labs
0
Avg purity
99.63%
±0.35%
Endotoxin tested
67%
This platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs